Hit finding is the identification of the first active compounds at a new target.
ChemDiv is capable to offer screening services for biochemical, functional and/or cellular morphological responses using its well validated molecular screening technology platforms. This can be achieved and facilitated through access to our proprietary collection of 1.6M+ small molecule screening compounds or using the client’s compound library.
Our HTS – high throughput screening – technology platform includes all types of luminescent, fluorescent and absorption readouts, including FLIPR and multimode plate readers.
ChemDiv is offering its expertise and more than 30 years of experience in assay development, covering the major target classes. The Hit Finding can also be significantly improved through our access to high-through crystallography and comprehensive structure-based design platforms.
ChemDiv has assembled a robust high throughput screening platform encompassing automated liquid handling and multimode signal detection equipment for assays to be ran in up to 1536-well plate formats. Multimode reading capability provides access to screening assays with multiplicity of targets, such as receptors, enzymes, signaling pathways etc. that play a major role in different therapeutics areas (oncology, immunology, CNS, metabolic diseases).
ChemDiv offers logistics and compound handling support to High Throughput Screening (HTS) performed at our facilities, which substantially reduces time and eliminates costs associated with screening compounds shipments and plate preparations. Decades of stellar experience of being a worldwide manufacturer and supplier of compound libraries to drug discovery institutions, uniquely positions ChemDiv, with its logistics infrastructure, to be able to backtrack every hit to its specific QC data for the original screening compound on the plate. Our proprietary focused discovery sub-libraries assembled from the ChemDiv’s ever-growing collection of 1.6 million small molecules, being synthesized based on novel templates ideas, provide tremendous benefits for high throughput hit hunting in terms of both potential hit novelty and follow up synthetic hit expansion. Unique design of these sublibraries provides a very robust way for early chemoinformatics-based identification and confirmation of hit compounds with immediate mini-SAR cluster analyses offering seed scaffolds, or starting points, for hit expansion, hit-to-lead exploration, and medicinal chemistry lead optimization.
We have assembled a robust screening infrastructure to be able to work with targets of major therapeutics areas. Our technical park of Discovery Division includes:
Biomek FX work station
96/384-well plate readers;
FLIPR-Tetra (Molecular Devices)
Microbeta PLUS 1450 (PerkinElmer),
Victor2V and Victor 3 multimode;
SpectraMax Plus 96/384;
Mach III (Tomtec) 96-well cell harvester;
Beckman and GUAVA 96/384 well format Flow Cytometers.